Reposted by D. Yates
After favorable results in human tissue and animal models, researchers hope to begin clinical trials by fall 2025 to test the safety of drugs that provide COVID's cancer-fighting properties without the illness. www.jci.org/articles/vie...
JCI -
Inducible CCR2+ nonclassical monocytes mediate the regression of cancer metastasis
www.jci.org
December 6, 2024 at 7:28 PM
After favorable results in human tissue and animal models, researchers hope to begin clinical trials by fall 2025 to test the safety of drugs that provide COVID's cancer-fighting properties without the illness. www.jci.org/articles/vie...